Open-label Trial
An open-label trial is a clinical study in which both participants and investigators know which medicine or treatment each participant is receiving.
An open-label trial is a clinical study in which both participants and investigators know which medicine or treatment each participant is receiving.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
